Fingerprint
Dive into the research topics of 'Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis
Jonathan Hogan, Rupali Avasare, Jai Radhakrishnan
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations